{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:38:11Z","timestamp":1780490291973,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.amjmed.2018.10.033","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:48:12Z","timestamp":1542934092000},"page":"408-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Diabetes Care for Patients Experiencing Homelessness: Beyond Metformin and Sulfonylureas"],"prefix":"10.1016","volume":"132","author":[{"given":"Lauren K.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Kalyanaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2018.10.033_bib0001","series-title":"The 2017 Annual Homeless Assessment Report to Congress","author":"Henry","year":"2017"},{"issue":"1","key":"10.1016\/j.amjmed.2018.10.033_bib0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/pubmed\/fdx034","article-title":"Lifetime and 1-year prevalence of homelessness in the US population: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III","volume":"40","author":"Tsai","year":"2018","journal-title":"J Public Health (Oxf)"},{"issue":"4","key":"10.1016\/j.amjmed.2018.10.033_bib0003","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.2105\/AJPH.2014.302330","article-title":"Diabetes and hypertension prevalence in homeless adults in the United States: a systematic review and meta-analysis","volume":"105","author":"Bernstein","year":"2015","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.amjmed.2018.10.033_bib0004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1025152403545","article-title":"Association between time homeless and perceived health status among the homeless in San Francisco","volume":"22","author":"White","year":"1997","journal-title":"J Community Health"},{"issue":"11","key":"10.1016\/j.amjmed.2018.10.033_bib0005","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s11606-016-3786-z","article-title":"Differential impact of homelessness on glycemic control in veterans with type 2 diabetes mellitus","volume":"31","author":"Axon","year":"2016","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0006","first-page":"84","article-title":"Lack of housing, hospital treatment and premature mortality: a cohort study of people in Counties Manukau district","volume":"129","author":"Thornley","year":"2016","journal-title":"N Z Med J"},{"issue":"11","key":"10.1016\/j.amjmed.2018.10.033_bib0007","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11892-016-0810-y","article-title":"Access to diabetes care for populations experiencing homelessness: an integrated review","volume":"16","author":"White","year":"2016","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0008","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/726568","article-title":"Ill, itinerant, and insured: the top 20 users of emergency departments in Baltimore city","volume":"2012","author":"DiPietro","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0009","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2337\/dc11-0701","article-title":"Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors","volume":"34","author":"Randall","year":"2011","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.amjmed.2018.10.033_bib0010","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.jada.2007.08.006","article-title":"The food insecurity-obesity paradox: a review of the literature and the role food stamps may play","volume":"107","author":"Dinour","year":"2007","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0011","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1017\/S1368980015002384","article-title":"Prevalence and covariates of food insecurity among residents of single-room occupancy housing in Chicago, IL, USA","volume":"19","author":"Bowen","year":"2016","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0012","first-page":"E04","article-title":"Screening for food insecurity in six veterans administration clinics for the homeless, June-December 2015","volume":"14","author":"O'Toole","year":"2017","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0013","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.socscimed.2017.06.044","article-title":"Pathways between childhood\/adolescent adversity, adolescent socioeconomic status, and long-term cardiovascular disease risk in young adulthood","volume":"188","author":"Doom","year":"2017","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0014","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1161\/CIRCULATIONAHA.104.510826","article-title":"Risk factors for cardiovascular disease in homeless adults","volume":"111","author":"Lee","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.amjmed.2018.10.033_bib0015","doi-asserted-by":"crossref","first-page":"R245","DOI":"10.1530\/EJE-18-0022","article-title":"Antipsychotic medication and type 2 diabetes and impaired glucose regulation","volume":"178","author":"Whicher","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.amjmed.2018.10.033_bib0016","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3371\/CSRP.GOPA.013114","article-title":"Adherence to diabetes medication in individuals with schizophrenia: a systematic review of rates and determinants of adherence","volume":"10","author":"Gorczynski","year":"2017","journal-title":"Clin Schizophr Relat Psychoses"},{"issue":"4","key":"10.1016\/j.amjmed.2018.10.033_bib0017","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/1534734616661058","article-title":"Treatment failure and leg amputation among patients with foot osteomyelitis","volume":"15","author":"Barshes","year":"2016","journal-title":"Int J Low Extrem Wounds"},{"issue":"12","key":"10.1016\/j.amjmed.2018.10.033_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167463","article-title":"Foot conditions among homeless persons: a systematic review","volume":"11","author":"To","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0019","series-title":"Insurance coverage at health care for the homeless projects, 2013-2015","author":"DiPietro","year":"2017"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0020","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0021","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.298.2.194","article-title":"Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis","volume":"298","author":"Amori","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0022","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.2017.14752","article-title":"Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial","volume":"318","author":"Davies","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.amjmed.2018.10.033_bib0023","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/dom.12849","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis","volume":"19","author":"Htike","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2018.10.033_bib0024","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/dom.13162","article-title":"A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials","volume":"20","author":"Aroda","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0025","first-page":"534","article-title":"Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study","volume":"173","author":"Singh","year":"2013","journal-title":"JAMA Intern\u00a0Med"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0026","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/jamainternmed.2016.1522","article-title":"Association between incretin-based drugs and the risk of acute pancreatitis","volume":"176","author":"Azoulay","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0027","doi-asserted-by":"crossref","first-page":"g2366","DOI":"10.1136\/bmj.g2366","article-title":"Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies","volume":"348","author":"Li","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0028","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/dom.12926","article-title":"Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials","volume":"19","author":"Monami","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0029","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2018.10.033_bib0030","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"9733","key":"10.1016\/j.amjmed.2018.10.033_bib0031","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(10)60407-2","article-title":"Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial","volume":"375","author":"Bailey","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.amjmed.2018.10.033_bib0032","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/jc.2011-2260","article-title":"Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin","volume":"97","author":"Bolinder","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.amjmed.2018.10.033_bib0033","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2337\/dc14-1096","article-title":"Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension","volume":"38","author":"Tikkanen","year":"2015","journal-title":"Diabetes Care"},{"issue":"22","key":"10.1016\/j.amjmed.2018.10.033_bib0034","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.amjmed.2018.10.033_bib0035","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amjmed.2018.10.033_bib0036","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1053\/j.jfas.2011.04.030","article-title":"Foot and shoe size mismatch in three different New York City populations","volume":"50","author":"Schwarzkopf","year":"2011","journal-title":"J Foot Ankle Surg"},{"issue":"4","key":"10.1016\/j.amjmed.2018.10.033_bib0037","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1745-7599.2011.00598.x","article-title":"Utilization of foot care services among homeless adults: implications for advanced practice nurses","volume":"23","author":"Muirhead","year":"2011","journal-title":"J Am Acad Nurse Pract"},{"issue":"22","key":"10.1016\/j.amjmed.2018.10.033_bib0038","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.amjmed.2018.10.033_bib0039","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2337\/diacare.23.11.1605","article-title":"Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group","volume":"23","author":"Aronoff","year":"2000","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.amjmed.2018.10.033_bib0040","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00019501-200108000-00011","article-title":"The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus","volume":"12","author":"Rosenblatt","year":"2001","journal-title":"Coron Artery Dis"},{"issue":"7","key":"10.1016\/j.amjmed.2018.10.033_bib0041","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diacare.28.7.1547","article-title":"A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia","volume":"28","author":"Goldberg","year":"2005","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.amjmed.2018.10.033_bib0042","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-J\u00e4rvinen","year":"2004","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.amjmed.2018.10.033_bib0043","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jacc.2006.12.048","article-title":"The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study","volume":"49","author":"Erdmann","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.amjmed.2018.10.033_bib0044","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials","volume":"298","author":"Lincoff","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.amjmed.2018.10.033_bib0045","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/dc10-1068","article-title":"Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study","volume":"34","author":"Lewis","year":"2011","journal-title":"Diabetes Care"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431831074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431831074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:16:46Z","timestamp":1757582206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293431831074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S000293431831074X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.10.033","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes Care for Patients Experiencing Homelessness: Beyond Metformin and Sulfonylureas","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}